These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 21159492)

  • 1. The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study.
    Kern RS; Gold JM; Dickinson D; Green MF; Nuechterlein KH; Baade LE; Keefe RS; Mesholam-Gately RI; Seidman LJ; Lee C; Sugar CA; Marder SR
    Schizophr Res; 2011 Mar; 126(1-3):124-31. PubMed ID: 21159492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia.
    Burton CZ; Vella L; Harvey PD; Patterson TL; Heaton RK; Twamley EW
    Schizophr Res; 2013 May; 146(1-3):244-8. PubMed ID: 23507359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives.
    Mucci A; Galderisi S; Green MF; Nuechterlein K; Rucci P; Gibertoni D; Rossi A; Rocca P; Bertolino A; Bucci P; Hellemann G; Spisto M; Palumbo D; Aguglia E; Amodeo G; Amore M; Bellomo A; Brugnoli R; Carpiniello B; Dell'Osso L; Di Fabio F; di Giannantonio M; Di Lorenzo G; Marchesi C; Monteleone P; Montemagni C; Oldani L; Romano R; Roncone R; Stratta P; Tenconi E; Vita A; Zeppegno P; Maj M;
    Psychol Med; 2018 Jun; 48(8):1359-1366. PubMed ID: 29017620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdiagnostic validity of the MATRICS Consensus Cognitive Battery across the autism-schizophrenia spectrum.
    Kuo SS; Wojtalik JA; Mesholam-Gately RI; Keshavan MS; Eack SM
    Psychol Med; 2020 Jul; 50(10):1623-1632. PubMed ID: 31298174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An empirical evaluation of the MATRICS Consensus Cognitive Battery in bipolar disorder.
    Van Rheenen TE; Rossell SL
    Bipolar Disord; 2014 May; 16(3):318-25. PubMed ID: 24119238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Brazilian standardization of the MATRICS consensus cognitive battery (MCCB): Psychometric study.
    Fonseca AO; Berberian AA; de Meneses-Gaya C; Gadelha A; Vicente MO; Nuechterlein KH; Bressan RA; Lacerda ALT
    Schizophr Res; 2017 Jul; 185():148-153. PubMed ID: 28110814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MATRICS consensus cognitive battery--standard for the assessment of cognitive functions in clinical trials in schizophrenia].
    Jedrasik-Styła M; Ciołkiewicz A; Denisiuk M; Linke M; Parnowska D; Gruszka A; Jarema M; Wichniak A
    Psychiatr Pol; 2012; 46(2):261-71. PubMed ID: 23214396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MATRICS cognitive consensus battery (MCCB) performance in children, adolescents, and young adults.
    Nitzburg GC; Derosse P; Burdick KE; Peters BD; Gopin CB; Malhotra AK
    Schizophr Res; 2014 Jan; 152(1):223-8. PubMed ID: 24321710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MCCB impairment profile in a Spanish sample of patients with schizophrenia: Effects of diagnosis, age, and gender on cognitive functioning.
    Rodriguez-Jimenez R; Dompablo M; Bagney A; Santabárbara J; Aparicio AI; Torio I; Moreno-Ortega M; Lopez-Anton R; Lobo A; Kern RS; Green MF; Jimenez-Arriero MA; Santos JL; Nuechterlein KH; Palomo T
    Schizophr Res; 2015 Dec; 169(1-3):116-120. PubMed ID: 26416441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment profile in adolescent early-onset psychosis using the MATRICS Battery: Age and sex effects.
    Smelror RE; Johannessen C; Wedervang-Resell K; Jørgensen KN; Barth C; Andreou D; Ueland T; Andreassen OA; Myhre AM; Rund BR; Agartz I
    Neuropsychology; 2021 Mar; 35(3):300-309. PubMed ID: 33970663
    [No Abstract]   [Full Text] [Related]  

  • 12. Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment.
    McCleery A; Ventura J; Kern RS; Subotnik KL; Gretchen-Doorly D; Green MF; Hellemann GS; Nuechterlein KH
    Schizophr Res; 2014 Aug; 157(1-3):33-9. PubMed ID: 24888526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Polish Academic Version of the MATRICS Consensus Cognitive Battery (MCCB): Evaluation of Psychometric Properties.
    Jędrasik-Styła M; Ciołkiewicz A; Styła R; Linke M; Parnowska D; Gruszka A; Denisiuk M; Jarema M; Green MF; Wichniak A
    Psychiatr Q; 2015 Sep; 86(3):435-47. PubMed ID: 25601030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and symptomatic predictors of functional disability in schizophrenia.
    Shamsi S; Lau A; Lencz T; Burdick KE; DeRosse P; Brenner R; Lindenmayer JP; Malhotra AK
    Schizophr Res; 2011 Mar; 126(1-3):257-64. PubMed ID: 20828991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB).
    McCleery A; Green MF; Hellemann GS; Baade LE; Gold JM; Keefe RS; Kern RS; Mesholam-Gately RI; Seidman LJ; Subotnik KL; Ventura J; Nuechterlein KH
    Psychol Med; 2015; 45(12):2657-66. PubMed ID: 25916421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial.
    Keefe RS; Fox KH; Harvey PD; Cucchiaro J; Siu C; Loebel A
    Schizophr Res; 2011 Feb; 125(2-3):161-8. PubMed ID: 21075600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers.
    Stone WS; Mesholam-Gately RI; Giuliano AJ; Woodberry KA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; McCarley RW; Heinssen R; Green MF; Nuechterlein K; Seidman LJ
    Schizophr Res; 2016 Apr; 172(1-3):106-13. PubMed ID: 26896388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometric characteristics of the MATRICS Consensus Cognitive Battery in a large pooled cohort of stable schizophrenia patients.
    Georgiades A; Davis VG; Atkins AS; Khan A; Walker TW; Loebel A; Haig G; Hilt DC; Dunayevich E; Umbricht D; Sand M; Keefe RSE
    Schizophr Res; 2017 Dec; 190():172-179. PubMed ID: 28433500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal comparison of two neurocognitive test batteries in patients with schizophrenia and healthy volunteers: Time effects on neuropsychological performance and their relation to functional outcome.
    Rodriguez-Toscano E; López G; Mayoral M; Lewis S; Lees J; Drake R; Arango C; Rapado-Castro M
    Schizophr Res; 2020 Feb; 216():347-356. PubMed ID: 31813804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calibration and cross-validation of MCCB and CogState in schizophrenia.
    Lees J; Applegate E; Emsley R; Lewis S; Michalopoulou P; Collier T; Lopez-Lopez C; Kapur S; Pandina GJ; Drake RJ
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):3873-82. PubMed ID: 26018529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.